Home/HasenTech/Lisa M. Minter, PhD

LM

Lisa M. Minter, PhD

Member, Board of Directors

Therapeutic Areas

Graft-versus-Host Disease (GvHD)Inflammatory Disease Autoimmune Disease

HasenTech Pipeline

Drug	Indication	Phase
HT-01	Prevention of Graft-versus-Host Disease (GvHD) post bone marrow transplant	Pre-clinical

Leadership Team at HasenTech

Katherine L. Knight, PhD

Barbara A. Osborne, PhD

Richard A. Goldsby, PhD

Patrick J. Stiff, MD

Member, Board of Directors

View full HasenTech profile